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Summary
The safety of veterinary vaccines is assessed in clinical trials in Europe. The assessment of the local tissue reaction to 
vaccination by magnetic resonance imaging (MRI) could reduce the number of animals needed because repeated 
examinations can be performed in the same animal over time. The present study compared the evaluation of local 
tissue reactions to vaccination using MRI in live pigs with histopathology of porcine tissue, the current gold standard in 
regulatory safety testing. Eight piglets each were administered one of two commercial vaccines into marked injection 
sites. All animals were sedated and scanned repeatedly by MRI using a contrast agent up to day 29 after vaccination. 
On day 29, the animals were euthanized and underwent a pathological examination. The MRI results were compared 
with the pathomorphological findings at the injection site by regression analysis. The MR images and the pathological 
examinations yielded matching results concerning the sizes of the affected tissue volumes or areas. The use of MRI 
for regulatory safety testing can reduce the number of animals needed to 8 per examination group. The volume of a 
local reaction and its progression over time can be evaluated and documented. If persistent lesions develop a final 
pathomorphological examination is needed to identify the kind and local distribution of the reaction. 
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1  Introduction 
Local reactions are possible side effects of vaccination. These 
are mostly small and transient in the case of live viral vaccines 
but are often more pronounced in case of inactivated vaccines 
owing to the use of adjuvants. Adjuvant-induced local inflam-
matory reactions at the injection site are common but vary in ex-
tent depending on adjuvant type (Day, 2006; Patel and Heldens, 
2009; Spickler and Roth, 2003). 
Although veterinary vaccines undergo preclinical and clinical 
testing to ensure the safety of a product, the frequency and ex-
tent of side effects, like swelling, pain, granulomas or systemic 
effects such as fever or shock symptoms (Martinod, 1995; Roth, 
1999) needs to be evaluated in field trials. These safety tests are 
mandated by the European Pharmacopoeia and other legal regu-
lations for immunobiologicals (EC, 2001; EDQM, 2008). They 
demand a large number of animals, since all age categories of 
the target animal species for which the vaccine is intended must 
be tested and the local reaction has to be examined after vacci-
nation including a pathomorphological examination of the vac-
cination site (EC, 2001; EDQM, 2008). 
Imaging methods can be used to visualize tissue changes in 
the living proband. In human medicine magnetic resonance im-
aging (MRI) is an approved method for diagnosis and follow-
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up of musculoskeletal diseases (Kuo and Carrino, 2007; Messi-
neo et al., 1998; Schedel et al., 1992; Walker, 2008; Young and 
Bydder, 2003). MRI has been used in mice to evaluate antigen 
clearance after vaccination (Brewer et al., 2014). Other studies 
reported the use of imaging technologies in pharmacological 
research (Rudin, 1994; Rudin et al., 1995). Concerning mus-
cle tissue, various alterations resulting from trauma, infection, 
inflammation or edema can be detected using MRI (Lovitt et 
al., 2006; May et al., 2000; Schrank et al., 2005; Shellock et 
al., 1996; Pathria and Boutin, 2009) due to signal intensity 
changes, especially when performing different protocols (T1- 
and T2-weightenings; see Hodgson, 2010; Pipe, 1999). Local 
reactions can be detected via MRI (Brewer et al., 2014; Rudin, 
1994; Rudin et al., 1995) and results of our own study in pigs 
(Bernau et al., 2015) showed that MRI allows the documenta-
tion of local reactions after vaccination in the live pig, scanned 
repeatedly over 29 days.
In this study, we repetitively evaluated the volumes of local 
reaction after vaccination with commercial veterinary vaccines 
via MRI over a maximum of 29 days in pigs. To verify the 
results, the animals were euthanized on the last day of MRI 
examination and underwent a histopathological examination of 
the injection site.
2  Animals and methods
2.1  Animals
For this study 16 German Landrace piglets were randomly di-
vided into two experimental groups (n=8; Tab. 1). All animals 
were kept according to the German national animal welfare 
regulations (Germany, 2013; German Federal Ministry for 
Food, Agriculture and Consumer Protection, 2009; EU, 2010, 
Directive 2010/63/EU). The animal experiment was licensed 
by the District Government of Upper Bavaria (registry number: 
55.2-1-54-2532-138-11). The animals were born and raised 
on a conventional pig farm. They were housed in groups. All 
boxes were enriched with balls and metal chains equipped with 
diverse chewable material to satisfy their natural behavior. 
The pigs were marked using a circular tattoo needle (diame-
ter 0.3 cm) on the left neck skin (vaccination side) three weeks 
before the animals reached the specified vaccination age. Two 
commercial vaccines were used, both with 2 ml injection vol-
ume. Each group of piglets was injected intramuscularly with 
one vaccine into the center of the tattoo circle when they were 
approximately 6 weeks old. The composition of the vaccines is 
shown in Table 1. All animals were healthy and had not been 
vaccinated prior to the experiment.
2.2  Magnetic Resonance Imaging (MRI)
MRI test procedure
For this study an open low-field MRI system (Siemens Mag-
netom Open; 0.2 Tesla magnetic field strength) was used to 
detect and evaluate the local reaction inside the neck region of 
the pigs. All pigs had to be anaesthetized for MR scanning to 
avoid movement and to guarantee an excellent image quality. 
Anesthesia was performed with a combination of azaperone (2 
mg per kg body weight) and ketamine (10-15 mg per kg body 
weight) given intramuscularly (Germany, 2005). Anesthetics 
were injected into the hind leg muscles to avoid any interaction 
with vaccination-induced tissue changes at the neck. None of 
the animals received any injection into the neck musculature 
prior to experimental vaccination. 
The piglets were vaccinated at day 0 and examined by MRI 
at days 1, 3, 8, 15, 22 and 29 after vaccination. Up to now, only 
the results of day 29, the scheduled end of the study, were used 
for comparison with the pathomorphological examination as 
described below. 
Each animal underwent T1- and T2- weighted sequences 
with two directions of acquisition (coronal and axial), using 
the small body coil as receiver. The corresponding sequence 
parameters are shown in Table 2. All pigs were bedded in a 
prone position with front limbs flexed and hind limbs extended. 
Prone bedding is necessary to evaluate both neck sides simul-
taneously without creating artifacts due to the bedding. The 
vaccination point was positioned in the middle of the coil. 
A Gadolinium-based contrast agent (Gadobutrol, Bayer Vital 
GmbH, Leverkusen; 0.3 mmol per kg body weight) was admin-
istered via intravenous injection in order to improve the detec-
tion of potential local reactions in the MR images. Gadobutrol 
is a nonionic macrocyclic extracellular MRI contrast agent with 
a high T1 relaxivity, which reduces the T1 relaxation time and 
therefore increases the signal intensity in T1-weighted MR im-
ages (Bayer Health Care, 2011; Vogler et al., 1995). Because 
Gadobutrol is not listed in the Annex of Directive EC 470/2009 
(EC, 2009), its use is not permitted in animals intended for hu-
man consumption. 
For MRI examination the following protocol was used: 
1.  T1-weighted spin echo sequence with coronal acquisition, 
native without contrast agent use (T1cn)
Tab. 1: Animal description, subdivided into the examination groups with the number of animals (n), gender, average  
weight at the first and last examination day and vaccine ingredients
group n gender Ø weight (kg)  vaccine ingredients
   first day last day
I 8 4♂+4♀ 12.5 ± 1.5 24.1 ± 3.7 Mycoplasma hyopneumoniae I, light mineral oil, aluminium  
     (as hydroxide), thiomersal
II 8 4♂+4♀ 10.1 ± 1.4 16.6 ± 3.6 Mycoplasma hyopneumoniae II, carbopol, thiomersal
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A whole body necropsy was performed to evaluate the health 
status of the animal. Furthermore, the whole neck region was ex-
amined and sampled. Tissue up to the level of the spine was re-
moved and underwent fixation in 4%-formaldehyde solution for 
two days. After this time, neck regions were sliced transversally, 
in about 1 cm thick slices, from both sides up to a distance of one 
centimeter to the application site. Every slice was carefully evalu-
ated for the presence of pathological changes including discol-
orations, heterogeneity of tissue architecture, fluid accumulations 
or foreign structures and compared to the contralateral side. Any 
pathological change was noted and its dimension was measured 
at the level of the widest extent on a cutting surface by ruler.
The remaining slice of 2 cm thickness was trimmed from later-
ally up to a distance of 1 cm to the injection site. The remaining 
tissue block was horizontally cut into slices of 3 mm thickness 
and numbered, beginning at the level of the skin (Fig. 1). Every 
slice was postfixed for a further 24 h in 4%-formaldehyde so-
lution. Afterwards, the slices underwent paraffin embedding or 
glycol-methacrylate-methylmethacrylate (GMA-MMA) embed-
ding in an alternate manner, beginning with the skin by paraffin 
embedding. 
Standard staining procedures (H&E and Giemsa) were per-
formed in every level of both paraffin and GMA-MMA samples. 
Histopathological examination was performed by two independ-
ent pathologists. Any lesion was noted and the extent of inflam-
mation was estimated in percentage (%) of each slide. First, max_
extent (%) was calculated as mean of the slides with maximum 
extent of inflammation per group. Second, av_extent (%) was cal-
culated as mean of all slides showing inflammation per group. 
2.4  Statistical analysis
For the statistical analysis, the average MRI volume difference 
(Vol_diff) between VS and CS (including the standard error) 
was calculated for each sequence and tested against zero by 
2.  Intravenous application of Gadobutrol (0.3 mmol per kg 
body weight)
3.  T2-weighted spin echo sequence with the same coronal 
acquisition as T1cn (T2c)
4.  T1-weighted spin echo sequence with the same coronal 
acquisition as T1cn, with contrast agent (T1cCA)
5.  T1-weighted spin echo sequence with axial acquisition, 
with contrast agent (T1aCA)
(T1 = T1-weighted; T2 = T2-weighted; c = coronal  
acquisition; a = axial acquisition; n = native, without contrast 
agent; CA = with contrast agent)
MR image evaluation
For image evaluation the Able 3D Doctor® Software (Able 
Software Corp. Lexington, MA, USA. 2007: ASC 3DDR-
BN#07032 (FDA approved)) was used, in order to measure the 
local reaction. The volumes of regions with increased signal in-
tensity at the vaccination side (VS) and at the control side (CS) 
were bordered semiautomatically at defined signal intensities 
on a grey scale level from 0 (black) - 4096 (white) (Bernau et 
al., 2015). A region of interest (ROI) was created to cover the 
largest extent of the area with increased signal intensity at the 
VS. Inside this ROI, regions with grey values close to white 
(increased signal intensities) were classified as hyper-intense 
regions. Within the same image the ROI of the VS was mirrored 
to the CS. Regions inside CS with the same thresholds for signal 
intensity as on the VS were bordered as well. Five images from 
each sequence – starting at the injection point – were evaluated 
in ventral direction accordingly to create volumes of interest.
2.3  Pathomorphological examination
On day 29 after vaccination, the animals were euthanized in 
narcosis by an intracardial injection of sodium pentobarbital 
(Euthadorm®, CP-Pharma; 80 mg per kg body weight). 
Fig. 1: Schematic description of the procedure of tissue 
trimming (IS = injection site)
Tab. 2: MRI parameters used for the examination, subdivided 
into the T1-weighted (T1) and the T2-weighted (T2) sequence
MRI parameter T1  T2
 coronary axial coronary
TR (ms) 814  814 5690
TE (ms) 17 17 102
pixel size 1.30 x 0.70 1.56 x 0.76 1.43 x 0.78
FOV (mm) 180 200 200
matrix 54%;  50%;  55%,  
 138 x 256 128 x 256 140 x 256
number of slices 22 22 22
slice thickness (mm) 4 4 4
distance factor 0.5 0.5 0.5
examination time 5 min 40 sec 5 min 15 sec 5 min 48 sec
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statistically significant for T1aCA (p = 0.02). This finding cor-
responded with the results of the pathomorphological examina-
tion, where group II showed a significantly larger average or 
maximum extent of inflammation compared to group I. 
Pathomorphological examination confirmed that none of the 
animals suffered from a disease process interfering with the aim 
of the study. On the last examination day, none of the animals 
showed any macroscopically visible alteration at the surface of 
the neck tissue. Only one of the piglets in group II showed a 
mild discoloration of muscle tissue with a diameter of 4 mm at 
the injection site. Microscopically, each vaccination resulted in 
a lesion of variable degree in all pigs of both groups. In detail, 
histological examination revealed granulomatous inflammation 
and the presence of foreign material at the injection sites of 
both groups. 
The results of the regression analysis are shown in Table 4 and 
Figure 3. Low to high regression coefficients (R2 = 0.05 - 0.56) 
were achieved for the relationship between MRI and pathomor-
phological data. Significant results (p < 0.05) were achieved 
when contrast agent was used during MR imaging (T1cCA_Vol_
diff; T1aCA_Vol_diff). The av_extent compared with the T2c_
Vol_diff showed also a significant relationship (p = 0.0047). The 
error term (root mean square error, RMSE) was largest, however, 
t-test using SAS 9.3 software (SAS Software 9.3. Institute Inc., 
Cary, North Carolina, USA, 2010), (Tab. 3). This t-test was 
also performed for the pathological variables (av_extent and 
max_extent; Tab. 3). 
In addition, a single regression analysis was performed using 
the individual MRI variables Vol_diff for each sequence and 
the individual pathological variables max_extent and av_extent 
(Tab. 4). 
The significance level was set to p = 0.05 in both cases. Fi-
nally, an unpaired t-test was applied for the comparison of the 
two vaccines, both for the MRI and the pathological data.
3  Results 
Data of the MRI examination and the pathomorphological ex-
amination (as av_extent and max_extent) both representing day 
29 after vaccination are displayed in Table 3 and are represented 
as one MR image per group and the corresponding histopatho-
logical images (overview and close up) in Figure 2. 
The coronal and axial T1-weighted sequences of group II 
taken after application of the contrast agent (T1cCA and T1aCA) 
showed greater volume differences than in group I that were 
Tab. 3: Mean volume differences for all used MRI sequences at day 29 after vaccination and means of  
the pathomorphological examinations
Group T1cn T1cCA T2c T1aCA       Pathological examination
 Vol_diff ± Se Vol_diff ± Se Vol_diff ± Se Vol_diff ± Se av_extent ± Se max_extent ± Se  
 (cm3) (cm3) (cm3) (cm3)  (%) (%) 
I  0.03 ± 0.03 0.09 ± 0.04 0.14 ± 0.29 -0.04 ± 0.04 11.54 ± 1.57 16.75 ± 4.06 
  (p = 0.08)  (p = 0.30)  (p = 0.004)
II 0.05 ± 0.08 0.37 ± 0.14 1.55 ± 0.72 0.19 ± 0.08 21.08 ± 2.60 31.25 ± 3.24 
  (p = 0.03) (p = 0.07) (p = 0.05)  
I vs. II p = 0.8 p = 0.08 p = 0.09 p = 0.02 p = 0.007 p = 0.01
t1cn = t1-weighted coronal sequence, native without contrast agent. t1cCA = t1-weighted coronal sequence, with contrast agent.  
t2c = t2-weighted coronal sequence. t1aCA = axial t1-weighted sequence, with contrast agent. Vol_diff describes the difference for  
the volume of interest from VS minus CS. All average volume differences are specified with the corresponding standard error (SE).  
av_extent = % of extent of local reaction in all affected slices; max_extent = % of maximum extent in one slice. P-values in parenthesis. 
The extents from pathological examination were all significantly different from zero (p = 0.05).
Tab. 4: Results of the regression analysis (significance level p-value < 0.05), with regression coefficient (R2),  
RMSE (cm3) and the corresponding p-value
Variable av_extent   max_extent
 R2 RMSe (cm3) p-value R2 RMSe (cm3) p-value
T1cn_Vol_diff 0.10 0.16 0.2269 0.05 0.17 0.4184
T1cCA_Vol_diff 0.55 0.22 0.0010 0.56 0.22 0.0009
T2c_Vol_diff 0.45 1.28 0.0047 0.24 1.50 0.0542
T1aCA_Vol_diff 0.52 0.15 0.0016 0.41 0.17 0.0079
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Fig. 2: MRI examination of a piglet, lying on the belly with front limbs flexed and hind limbs extended 
MR image of a piglet of group I (upper line) and of a piglet of group II (lower line) with the corresponding histopathologic image (overview 
and close up) of this animal of each group.
Group I: MRI: Small signal intensity increase at VS. Overview: focal extensive fibrosis and hypercellularity of the skeletal musculature. 
Close up: granulomatous inflammation with cytoplasmatic granular, slightly basophilic foreign material in macrophages next to nests of 
lymphocytes and plasma cells. 
Group II: MRI: Extended signal intensity increase at VS. Overview: focal extensive fibrosis and scarring of skeletal musculature and 
multifocal hypercellularity. Close up: granulomatous inflammation with presence of multinucleated giant cells and accumulation of 
homogeneous, azidophilic cytoplasmatic foreign material in macrophages next to nests of lymphocytes and plasma cells embedded in 
fibrous tissue. 
Fig. 3: Graphs of the regression analysis of the contrast agent MRI volume differences (T1cCA, T1aCA each in mm³)  
and the pathomorphological data (av_extent, max_extent each in %)
Group I as red squares and group II as black squares
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side VS – which were not detected in CS – were interpreted as 
an increase of interstitial water (edema), since pathologic fatty 
infiltration only results from muscle necrosis in chronic muscle 
disorders or denervation atrophy (Schrank et al., 2005). Un-
fortunately, these mild edematous residues were not detectable 
microscopically in this study. Trimming lesions of the tissue 
could have obscured mild edematous tissue distensions, espe-
cially when these were located at tissue interfaces. 
Regions with hyper-intense signals in T1-weighted MR im-
ages can represent inflamed tissue, fatty infiltration or hemato-
ma (May et al., 2000; Schrank et al., 2005). In the present study, 
pathomorphological examination confirmed an inflammatory 
process at the injection site in all animals. Since all other in-
jections were given into the ham muscle, the detected altera-
tions in the neck region can be solely related to the vaccination. 
Therefore, all regions with hyper-intense signal in T1-weighted 
images were attributed to local reactogenicity. 
The detected MRI volume differences varied depending on 
the vaccine used (Tab. 3). These variations could be due to the 
adjuvants of the vaccines, which are known to determine the 
extent and duration of the local reaction (Batista-Duharte et al., 
2013; Edelman, 1980; Gupta et al., 1993).
The pathomorphological examination confirmed a degree of 
local reaction that related to the MRI data (Tab. 4, Fig. 3) in-
dependently of the vaccine used. Nevertheless some factors in-
fluence the interpretation of both methods: first, MRI provides 
numerical values after image evaluation, whereas the volume 
of a lesion cannot be as easily ascertained histopathologically. 
Second, local reactions of small dimension could be underval-
ued in MR images, since the spatial resolution could be reduced 
due to a large voxel size. 
Both methods have advantages and limitations regarding 
the evaluation of local reactogenicity. For MRI, the user de-
fines the image contrast that is used to border the local reaction 
semi-automatically. A fully automated image analysis would 
be more objective and could secure inter-observer reliability. 
Nevertheless, using MRI offers a three-dimensional imaging 
tool and allows the evaluation of the whole neck region. Fur-
thermore, it can be performed repetitively on the live animal. 
Pathomorphological examination, on the other hand, represents 
only a segment of the whole neck tissue. The pathomorpho-
logical evaluation of the whole neck region is costly and time 
consuming and cannot be performed in routine safety testing. 
Therefore, it is imperative that the injection site is permanently 
marked over the whole examination period until pathomorpho-
logical examination is performed. The kind of cellular infil-
tration, tissue destruction and deposition of foreign materials 
can be examined microscopically. In addition, special staining 
methods and immunohistochemical analysis can help to ana-
lyze and interpret local reactions in more detail. 
5  Conclusion
Non-invasive MRI allows evaluation of the local reaction re-
peatedly in the same animal over the course of a clinical trial. 
for the relationship between the T2-weighted sequences and the 
pathomorphological data (1.28 and 1.5 cm³). RMSE was compa-
rably lower for the T1-weighted sequences (0.15 - 0.22 cm³).
Figure 3 shows the distribution of the data, with group I as 
red squares and group II as black squares. Both imaging direc-
tions (axial or coronal T1-weighted sequence after application 
of contrast agent) revealed the same tendency for both groups 
resulting in a tendency in animals of group II towards larger 
Vol_diff (MRI) and a larger histopathologically defined extent 
of inflammation than in animals of group I. 
4  Discussion
Injectable medicines for veterinary applications must be 
checked for local and systemic adverse effects during the de-
velopment and licensing process. The reactogenicity especially 
of adjuvanted vaccines at the injection site is of major impor-
tance because of animal welfare concerns. In target animal 
species intended for human consumption long-lasting local re-
actions may affect meat quality. In principle, every vaccine ex-
hibits a different extent of local reaction at the vaccination site 
mainly due to the interaction of the adjuvant(s) and the antigens 
(Spickler and Roth, 2003).
Vaccinations performed in the present study caused a detect-
able local reaction within the neck tissue of the pigs in both 
groups that was visible in MR images and confirmed by patho-
morphological examination (Fig. 2). 
For both methods, the detected local reactions varied regard-
ing their extent (Tab. 3, Fig. 2, 3). Both methods detected a 
higher Vol_diff (MRI; in all sequences) as well as a higher av_
extent and max_extent (pathological examination; Tab. 3, Fig. 
3) in group II on the last examination day. 
The use of the contrast agent Gadobutrol led to statistically 
significant results in group II, both for the coronary and axial 
T1-weighted sequences (Tab. 4, Fig. 3). Gadobutrol reduces T1 
relaxation time and increases the signal intensity in T1-weight-
ed MR images (Vogler et al., 1995). Here, the contrast agent 
highlighted small local reactions by semiautomatic image eval-
uation as confirmed by regression analysis (Tab. 4, Fig. 3).
Using multiple MR sequences, diverse pathologic alterations 
can be detected (Berquist et al., 1985). Pathologic conditions 
like hematoma, edema, fatty infiltration or inflammation result 
in hyper-intense signal alterations (visible as very bright vox-
els) in tissue parameters by different image weightings (Lovitt 
et al., 2006; May et al., 2000; Schrank et al., 2005). For this 
study, T1- and T2-weighted image sequences were used (Tab. 
2) and the image evaluation was performed by a semiautomatic 
bordering of hyper-intense signals at the VS and CS, in order 
to create volumes (see Vol_diff, Tab. 3). These created volumes 
describe local tissue reactions. 
Regions with hyper-intense signals in T2-weighted MR im-
ages represent an increase in fat or water (Lovitt et al., 2006; 
May et al., 2000) and additionally, inflammation or increased 
blood flow in the early stage of a myopathic condition (Schrank 
et al., 2005). In the present study all hyper-intense regions in-
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different commercial vaccines. In our study the use of a low 
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each examination day and for numerous vaccine preparation to 
gain experience for every animal species and category. 
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